Frederick Vogt
Interim President and Chief Executive Officer
CEO
General Counsel
Earnings-call appearances
-
Iovance Biotherapeutics, Inc. Q1 FY2026 Earnings Call2026-05-07
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q4 FY2025 Earnings Call2026-02-24
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q2 FY2025 Earnings Call2025-08-07
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2022 Earnings Call2022-11-03
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Iovance Biotherapeutics, Inc. (IOVA)